ClinicalTrials.gg
Sign In

Meningeal Neoplasms clinical trials

The registry lists 40 studies for Meningeal Neoplasms across more than 10 countries. 17 are recruiting or about to start. 13 of them are mainly about Meningeal Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13. Counting its 2 narrower conditions too, such as Meningioma: 427 studies, 145 open.

Get an email when these change. Save the Meningeal Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Recruiting
15
Completed
8
Active, not recruiting
6
Terminated
6
Not yet recruiting
2
Status unknown
2

Phase

Phase 1
18
Phase 2
12
Phase 4
1
Phase 3
1

Where

United States
26
Canada
4
Germany
2
United Kingdom
2
Singapore
1
Japan
1

Who runs them

M.D. Anderson Cancer Center (7) · H. Lee Moffitt Cancer Center and Research Institute (4) · National Cancer Institute (NCI) (3) · Sunnybrook Health Sciences Centre (2) · University Hospital Tuebingen (2) · Memorial Sloan Kettering Cancer Center (2) · British Columbia Cancer Agency (1) · MedSIR (1)

What is being tested here

Drugs under test in Meningeal Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Trastuzumab204
Tucatinib203
Capecitabine203
Nivolumab102
Rhenium Re 186 Obisbemeda101
Methotrexate101
SX-682101
Gadopiclenol101
Gadobutrol101
Mafosfamide002

Drug classes tested here Antimetabolites 3 open · Tyrosine kinase inhibitors (TKIs) 2 open · Immune checkpoint inhibitors 1 open

Coming up

0phase 3 studies under way
11studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 15 Meningeal Neoplasms studies recruiting now, 14 (93%) set no upper age limit and 1 (7%) stop at 75 or younger. 1 (7%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 15
AgeWomenMen
101 (7%)1 (7%)
1815 (100%)15 (100%)
3014 (93%)14 (93%)
4014 (93%)14 (93%)
5014 (93%)14 (93%)
6514 (93%)14 (93%)
7514 (93%)14 (93%)
8514 (93%)14 (93%)

Across all 40 studies, recruiting or not: 5% stop at 75 or younger and 3% at 65; 20% take children; 0% are for women only and 0% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 14, 2026.

Results posted1

Studies

Recruiting first, then most recently updated. Showing 40 of 40. search them.